Adrenaline
chiral molecule
hormone & neurotransmitter
controls: heart rate, blood vessel diameters, air passage diameter, metabolism
Adrenaline chemical structure
phenyl group with 2 hydoxyls, alkyl side chain with a hydroxyl group terminated with a secondary amine
mono-amine, family: catecholamine
Catecholamine
1,2-dihydroxybenzene
Adrenaline as a drug
agonist, treatment for anaphylaxis
reason: very fast treatment
Auvi-Q, epipen
Noradrenaline
replace N-mthyel with N-H
Potency
Adrenaline: same for alpha and beta
NA: greater potency for alpha
Adrenaline Biosynthesis
Adrenoceptors types
β1: increase heart rate, renin secretion from kidneys
β2 receptors: relax bronchi, stimulate insulin release, inhibit histamine release from mast cells
Isoetharine
3rd generation
ultra-short acting
β2 selectivity obtained by:
Ultra-short acting (<3 hrs) due to:
Taken up by tissues and mutilated by the enzyme catechol-O-methyl-transferase (COMT) to form an inactive metabolite
Fix:
Replaced meta-OH with -CH2OH –> more resistant to metabolism
Isoprenaline non-specificity
Isoprenaline, acts on β1 (heart) & β2 (bronchi) –> mortality epidemic
Discovered when small doses given to hypoxemic dogs. Hypoxemia is common is asthmatic patients.
Salbutamol is 7 times less potent in raising heart rate in humans
Isoprenaline non-specificity
Isoprenaline, acts on β1 (heart) & β2 (bronchi) –> mortality epidemic
Discovered when small doses given to hypoxemic dogs. Hypoxemia is common is asthmatic patients.
Salbutamol is 7 times less potent in raising heart rate in humans
Fenoterol
short-acting β2 agonist
can activate β1 receptors at doses higher than recommended
withdrawn from NZ due to mortality issues thought to be due to excessive usage for severe asthma attacks in absence of medical assistance, up to 80 puffs before seeking medical attention
Adrenoreceptors SAR
Important features:
Salbutamol
short-acting (4-6 hours)
same potency as isoprenaline but less active on the heart
meta-CH2OH group –> longer duration and more resistant to metabolism by COMT
bulky tert-butyl group at amine:
salbutamol enantiomers
R enantiomer is more active but marketed it as a racemate becuase S blocks the metobolism of R
Salmeterol
treatment of nocturnal asthma (arnd 4 am)
increased length of the N-alkyl substituent with a hydrocarbon chain and aromatic ring:
-increased lipophilicity to bind more strongly to tissue in the vicinity of the adrenoreceptors –> longer duration of action (2x longer than salbutamol, 12 hours)
R enantiomer more active
meta-CH2OH –> higher bioavailabilty
bulky R-group: β2 selectivity & higher lipophilicity
Salmeterol vs Salbutamol
slower onset of action due to:
initially diffuse into plasma membrane of lung cells and
slow release back outside the cell to receptors –> suitable for prevention rather than relief of asthma attacks
-longer duration of action due to:
accumulate in plasma membrane then release over time to receptors–> nocturnal asthma
SAR
Structure-Activity Relationship
Steroids structure
Steroids in humans
mineralocorticoids: renal and blood function, water and electrolyte balance
Steroids as meds
Cortisone
21 carbon glucocorticoid
released in reaction to stress
released with adrenaline and elevate blood pressure to prep for fight or flight response
Cortisone as a med
Corticosteroids and arthritis